Cleared Traditional

K231536 - eQUANT System (FDA 510(k) Clearance)

Feb 2024
Decision
254d
Days
Class 2
Risk

K231536 is an FDA 510(k) clearance for the eQUANT System. This device is classified as a Positive Blood Culture Processor For Inoculum Preparation Used For Antimicrobial Susceptibility Testing (Class II - Special Controls, product code QZX).

Submitted by Avails Medical, Inc. (Menlo Park, US). The FDA issued a Cleared decision on February 8, 2024, 254 days after receiving the submission on May 30, 2023.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1650. Processing Device That Includes Associated Reagents, When Applicable, That Is Intended To Recover Microbes From Positive Blood Cultures For Inoculum Preparation. The Prepared Inoculum Is Intended For Subsequent Use In Antimicrobial Susceptibility Testing..

Submission Details

510(k) Number K231536 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2023
Decision Date February 08, 2024
Days to Decision 254 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code QZX - Positive Blood Culture Processor For Inoculum Preparation Used For Antimicrobial Susceptibility Testing
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1650
Definition Processing Device That Includes Associated Reagents, When Applicable, That Is Intended To Recover Microbes From Positive Blood Cultures For Inoculum Preparation. The Prepared Inoculum Is Intended For Subsequent Use In Antimicrobial Susceptibility Testing.